Pilot Study to Evaluate a Noninvasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorders Following TAVI Implantation (IMPROVE Study)

Study to evaluate the efficacy and safety of a non-invasive electrocardiographic monitoring strategy associated with early discharge in patients with conduction disorder after transfemoral TAVI implantation, and its potential benefits compared to standard care.

NCT Number	NCT07456280
Lead Sponsor	Hospital Universitari Vall d'Hebron Research Institute
Conditions	Severe Aortic Valve Stenosis, Cardiovascular Diseases
Enrollment	100 participants
Start Date	2026-07-20
Primary Completion	2028-07-01 (estimated)
Study Completion	2028-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-22